Cargando…
Immunotherapy for B-Cell Lymphoma: Current Status and Prospective Advances
Therapy for non-Hodgkin’s lymphoma has progressed significantly over the last decades. However, the majority of patients remain incurable, and novel therapies are needed. Because immunotherapy ideally offers target selectivity, an ever increasing number of immunotherapies, both passive and active, a...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Research Foundation
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3342070/ https://www.ncbi.nlm.nih.gov/pubmed/22566889 http://dx.doi.org/10.3389/fimmu.2012.00003 |